Polycystic Ovary Syndrome and Cardiovascular Disease: A Premature Association?
- 1 June 2003
- journal article
- review article
- Published by The Endocrine Society in Endocrine Reviews
- Vol. 24 (3), 302-312
- https://doi.org/10.1210/er.2003-0004
Abstract
Women with polycystic ovary syndrome (PCOS) are often assumed, a priori, to be at increased risk for cardiovascular disease (CVD), given the high prevalence of the metabolic syndrome X among them. There is, however, no single definition of PCOS, and for that reason a comparison of studies that have analyzed its association with CVD is compromised from the start. Long-term studies of well characterized women with PCOS are lacking, and the link to primary cardiovascular events such as stroke or myocardial infarction remains more speculative than substantive. Epidemiological studies that have focused on isolated signs and stigmata of PCOS, such as polycystic ovaries, hyperandrogenism, or chronic anovulation, have found mixed results. There are studies that suggest a slight increase in cardiovascular events in women with polycystic ovaries, with perhaps stronger evidence between an increased risk of cardiovascular events in women with menstrual irregularity. However, there is little evidence for an association between hyperandrogenism per se and cardiovascular events. Furthermore, there are less data to substantiate an increased risk of events in women with PCOS identified on the basis of a combination of signs and symptoms, such as hyperandrogenic chronic anovulation. The existing data suggest that PCOS may adversely affect or accelerate the development of an adverse cardiovascular risk profile, and even of subclinical signs of atherosclerosis, but it does not appear to lower the age of clinical presentation to a premenopausal age group. Future studies to identify the risk of cardiovascular events in women with PCOS will benefit from clear and extensive phenotyping of PCOS abnormalities at baseline, from a prospective design, from larger sample sizes, and from longer follow-up.Keywords
This publication has 84 references indexed in Scilit:
- Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: A controlled, population-based studyAmerican Journal of Obstetrics and Gynecology, 2001
- Are Surrogate Markers Adequate to Assess Cardiovascular Disease Drugs?JAMA, 1999
- Andrology: Polycystic ovary syndrome: the spectrum of the disorder in 1741 patientsHuman Reproduction, 1995
- Diabetes and Cardiovascular Disease: The “Common Soil” HypothesisDiabetes, 1995
- Polycystic ovary syndrome and risk for myocardial infarction: Evaluated from a risk factor model based on a prospective population study of womenActa Obstetricia et Gynecologica Scandinavica, 1992
- Clinical signs of androgen excess as risk factors for coronary artery diseaseFertility and Sterility, 1990
- Role of Insulin Resistance in Human DiseaseDiabetes, 1988
- Characterization of Groups of Hyperaiidrogenic Women with Acanthosis Nigricans, Impaired Glucose Tolerance, and/or Hyperinsulinemia*Journal of Clinical Endocrinology & Metabolism, 1987
- Correlation of Hyperandrogenism with Hyperinsulinism in Polycystic Ovarian Disease*Journal of Clinical Endocrinology & Metabolism, 1980
- Amenorrhea associated with bilateral polycystic ovariesAmerican Journal of Obstetrics and Gynecology, 1935